Acquired resistance to infliximab against uveitis due to Behçet's disease after one year of administration.
Takako
T
Ito
Koh-Hei
KH
Sonoda
Kuniaki
K
Hijioka
Takeshi
T
Fujimoto
Tatsuro
T
Ishibashi
D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001528:Behcet Syndrome / Q000150:complications*; D004351:Drug Resistance; D006801:Humans; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D014605:Uveitis / Q000188:drug therapy* / Q000209:etiology; D055815:Young Adult
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D000069285:Infliximab